Piper Sandler analyst issues OVERWEIGHT recommendation for CRM on May 28, 2025 11:54AM ET. The previous analyst recommendation was Overweight.CRM was trading at $277.38 at issue of the analyst recommendation.The...
UBS analyst issues NEUTRAL recommendation for CRM on May 28, 2025 11:54AM ET. The previous analyst recommendation was Neutral.CRM was trading at $277.38 at issue of the analyst recommendation.The overall...
Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for HPQ on May 28, 2025 12:24PM ET. The previous analyst recommendation was Equal-Weight.HPQ was trading at $27.99 at issue of the analyst recommendation.The...
Seaport Global analyst issues CAUTIOUS recommendation for NVDA on May 23, 2025 04:07PM ET. NVDA was trading at $131.875 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current...
UBS analyst issues BUY recommendation for NVDA on May 23, 2025 04:07PM ET. The previous analyst recommendation was Buy.NVDA was trading at $131.875 at issue of the analyst recommendation.The overall...
Wedbush analyst issues CAUTIOUS recommendation for NVDA on May 23, 2025 04:07PM ET. The previous analyst recommendation was Outperform.NVDA was trading at $131.875 at issue of the analyst recommendation.The overall...
Morgan Stanley analyst issues HOLD recommendation for NVDA on May 23, 2025 04:07PM ET. The previous analyst recommendation was Hold.NVDA was trading at $131.875 at issue of the analyst recommendation.The...
Citigroup analyst issues BUY recommendation for BA on May 22, 2025 06:03PM ET. The previous analyst recommendation was Buy.BA was trading at $203.32 at issue of the analyst recommendation.The overall...
Wells Fargo analyst issues UNDERWEIGHT recommendation for BA on May 22, 2025 06:03PM ET. The previous analyst recommendation was Underweight.BA was trading at $203.32 at issue of the analyst recommendation.The...
TD Securities analyst issues CAUTIOUS recommendation for BA on May 22, 2025 06:03PM ET. BA was trading at $203.32 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current...
